QID 242822

Date Published: 2024-02-07

QID 242822: Red Hat Update for JBoss Enterprise Application Platform 7.4.1 (RHSA-2024:0710)

Red hat jboss enterprise application platform 7 is a platform for java applications based on the wildfly application runtime.
This release of Red Hat jboss enterprise application platform 7.4.15 serves as a replacement for Red Hat jboss enterprise application platform 7.4.14, and includes bug fixes and enhancements.
See the Red Hat jboss enterprise application platform 7.4.15 release notes for information about the most significant bug fixes and enhancements included in this release...Security Fix(es):

    santuario: private key disclosure in debug-log output [eap-7.4.z] (cve-2023-44483).
    Jgit: arbitrary file overwrite [eap-7.4.z] (cve-2023-4759).
<H2></H2>
    jboss enterprise application platform 7.4 for rhel 7 x86_64.
.

Note: The preceding description block is extracted directly from the security advisory. Using automation, we have attempted to clean and format it as much as possible without introducing additional issues.

Successful exploitation of this vulnerability could lead to a security breach or could affect integrity, availability, and confidentiality.

  • CVSS V3 rated as Critical - 8.8 severity.
  • CVSS V2 rated as Medium - 5.4 severity.
    • Solution
    Refer to Red Hat security advisory RHSA-2024:0710 for updates and patch information.
    Vendor References

    CVEs related to QID 242822

    CVE-2023-44483 | CVE-2023-4759 |
    Software Advisories
    Advisory ID Software Component Link
    RHSA-2024:0710 Red Hat Enterprise Linux URL Logo access.redhat.com/errata/RHSA-2024:0710
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].